Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin.

Fukushi J, Makagiansar IT, Stallcup WB.

Mol Biol Cell. 2004 Aug;15(8):3580-90. Epub 2004 Jun 4.

2.
3.

Molecular basis of interaction between NG2 proteoglycan and galectin-3.

Wen Y, Makagiansar IT, Fukushi J, Liu FT, Fukuda MN, Stallcup WB.

J Cell Biochem. 2006 May 1;98(1):115-27.

PMID:
16365873
4.

HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.

Mehta VB, Zhou Y, Radulescu A, Besner GE.

Growth Factors. 2008 Dec;26(6):301-15. doi: 10.1080/08977190802393596.

PMID:
18925469
5.

NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.

You WK, Yotsumoto F, Sakimura K, Adams RH, Stallcup WB.

Angiogenesis. 2014 Jan;17(1):61-76. doi: 10.1007/s10456-013-9378-1. Epub 2013 Aug 8.

7.

Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP.

Robinet A, Fahem A, Cauchard JH, Huet E, Vincent L, Lorimier S, Antonicelli F, Soria C, Crepin M, Hornebeck W, Bellon G.

J Cell Sci. 2005 Jan 15;118(Pt 2):343-56. Epub 2005 Jan 4.

8.

Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.

Chen N, Leu SJ, Todorovic V, Lam SC, Lau LF.

J Biol Chem. 2004 Oct 15;279(42):44166-76. Epub 2004 Aug 10.

9.

Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1).

McIlroy M, O'Rourke M, McKeown SR, Hirst DG, Robson T.

Cardiovasc Res. 2006 Jan;69(1):207-17. Epub 2005 Sep 13.

PMID:
16165110
10.

Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1.

Chandrasekaran L, He CZ, Al-Barazi H, Krutzsch HC, Iruela-Arispe ML, Roberts DD.

Mol Biol Cell. 2000 Sep;11(9):2885-900.

11.

Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis.

Bernardini D, Nasulewic A, Mazur A, Maier JA.

Front Biosci. 2005 May 1;10:1177-82.

PMID:
15769616
13.

In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis.

Koh W, Stratman AN, Sacharidou A, Davis GE.

Methods Enzymol. 2008;443:83-101. doi: 10.1016/S0076-6879(08)02005-3.

PMID:
18772012
14.

In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A.

Witmer AN, van Blijswijk BC, van Noorden CJ, Vrensen GF, Schlingemann RO.

J Histochem Cytochem. 2004 Jan;52(1):39-52.

PMID:
14688216
15.

Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.

Dorfleutner A, Hintermann E, Tarui T, Takada Y, Ruf W.

Mol Biol Cell. 2004 Oct;15(10):4416-25. Epub 2004 Jul 14.

16.

NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.

Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB.

Dev Dyn. 2001 Oct;222(2):218-27.

17.

Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.

Saito Y, Shiota Y, Nishisaka M, Owaki T, Shimamura M, Fukai F.

Biol Pharm Bull. 2008 May;31(5):1003-7.

18.
19.

HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways.

Mehta VB, Besner GE.

Growth Factors. 2007 Aug;25(4):253-63.

PMID:
18092233
20.

A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin.

Soro S, Orecchia A, Morbidelli L, Lacal PM, Morea V, Ballmer-Hofer K, Ruffini F, Ziche M, D'Atri S, Zambruno G, Tramontano A, Failla CM.

Blood. 2008 Apr 1;111(7):3479-88. doi: 10.1182/blood-2007-03-077537. Epub 2008 Jan 9.

Supplemental Content

Support Center